瑞普生物：拟转让中岸生物48.4213%股权

Core Viewpoint - The company plans to transfer 48.4213% equity stake in its subsidiary Zhong'an Bio to Jiangxi Twin Biological Technology Co., Ltd. for a transaction price of 115 million yuan, aiming to deepen strategic cooperation with aquaculture group clients and optimize asset and business structure [1] Group 1 - The transaction will result in the company holding a 20% equity stake in Zhong'an Bio after completion [1] - Zhong'an Bio will no longer be included in the company's consolidated financial statements following the transaction [1] - The transaction does not constitute a related party transaction or a major asset restructuring and is subject to approval by the company's shareholders' meeting [1]